Efficiency and side effects of anti-CD38 CAR T cells in an adult patient with relapsed B-ALL after failure of bi-specific CD19/CD22 CAR T cell treatment
Yelei Guo, Kaichao Feng, Chuan Tong, Hejin Jia, Yang Liu, Yao Wang, Dongdong Ti, Qingming Yang, Zhiqiang Wu, Weidong Han
Topics & Concepts
CD22CD19CD38MedicineInternal medicineB cellOncologyCancer researchImmunologyBiologyStem cellCell biologyPeripheral bloodAntibodyCD34CAR-T cell therapy researchImmune Cell Function and InteractionChronic Lymphocytic Leukemia Research